LRRC8 complexes are adenosine nucleotide release channels regulating platelet activation and arterial thrombosis
Tranter, J. D.; Mikami, R. T.; Kumar, A.; Brown, G.; Abd El-Aziz, T. M.; Zhao, Y.; Abraham, N.; Meyer, C.; Ajanel, A.; Xie, L.; Ashworth, K.; Hong, J.; Zhang, H.; Kumari, T.; Balutowski, A.; Liu, A.; Bark, D.; Nair, V. K.; Lasky, N. M.; Feng, Y.; Stitziel, N. O.; Lerner, D. J.; Campbell, R. A.; Di Paola, J.; Cho, J.; Sah, R.
Show abstract
Platelet shape and volume changes are early mechanical events contributing to platelet activation and thrombosis. Here, we identify single-nucleotide polymorphisms in Leucine-Rich Repeat Containing 8 (LRRC8) protein subunits that form the Volume-Regulated Anion Channel (VRAC) which are independently associated with altered mean platelet volume. LRRC8A is required for functional VRAC in megakaryocytes (MKs) and regulates platelet volume, adhesion, and agonist-stimulated activation, aggregation, ATP secretion and calcium mobilization. MK-specific LRRC8A cKO mice have reduced arteriolar thrombus formation and prolonged arterial thrombosis without affecting bleeding times. Mechanistically, platelet LRRC8A mediates swell-induced ATP/ADP release to amplify agonist-stimulated calcium and PI3K-AKT signaling via P2X1, P2Y1 and P2Y12 receptors. Small-molecule LRRC8 channel inhibitors recapitulate defects observed in LRRC8A-null platelets in vitro and in vivo. These studies identify the mechanoresponsive LRRC8 channel complex as an ATP/ADP release channel in platelets which regulates platelet function and thrombosis, providing a proof-of-concept for a novel anti-thrombotic drug target.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.